Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
DRREDDY Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Strong price momentum
Moderate revenue growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Analysts have been downgrading forward EPS estimates
Low dividend yield
Neutral
High ROE but declining trend
High operating margin but declining trend
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
DRREDDY Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
DRREDDY Bulk, Block & Insider Trades
DRREDDY Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(1 new shares for 1 existing shares)Bonus issue of 76757802 securities Ex-date: 28th Aug 2006 Announced on: 31st May 2006
Bonus(2 new shares for 1 existing shares) Ex-date: 8th Apr 1994 Announced on: 24th Mar 1994
Bonus(1 new shares for 1 existing shares) Ex-date: 4th Dec 1992
Bonus(1 new shares for 2 existing shares) Ex-date: 29th Oct 1991
Stock split(1 : 5)Nominal value change from INR 5 to INR 1. Ex-date: 28th Oct 2024 Announced on: 27th Jul 2024
Stock split(1 : 2) Ex-date: 10th Oct 2001 Announced on: 25th Sep 2001
Non-renounceable scrip issue in different stockBOD 31 March 2010. 6 Bonus Debentures for every 1 equity share of INR 5 each held. Ex-date: 17th Mar 2011 Announced on: 31st Mar 2010
Merger Ex-date: 1st Oct 2001 Announced on: 1st Oct 2001
MergerMerger of <AMRL.BO> with <REDY.BO>. The exchange ratio is 1 equity share of <REDY.BO> for every 12 equity shares in <AMRL.BO>. Ex-date: 13th Aug 2001 Announced on: 7th Mar 2000
MergerMerger of <CHDR.BO> with <REDY.BO>. 9 equity shares of <REDY.BO> will be allotted for every 25 equity shares of <CHDR.BO> held. Ex-date: 30th Jan 2001 Announced on: 30th Jan 2001
Company Profile
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of... Read More
Key personnel
Mr. Kallam Satish ReddyD
Executive Chairman of the Board
Mr. Gunupati Venkateswa PrasadD
Executive Co-Chairman, Managing Director
Mr. Erez Israeli
Chief Executive Officer
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Mr. Patrick Aghanian
Chief Executive Officer, European Generics
Mr. M. V. Ramana
Chief Executive Officer, Branded Markets (India and Emerging Markets)
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Dr. Reddys Laboratories Ltd.?
The current share price of Dr. Reddys Laboratories Ltd. is ₹ 1,209.78 as of 09 Jan 2026.
What is the PE ratio of Dr. Reddys Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Dr. Reddys Laboratories Ltd. is 17.45 as of the latest financial data.
What is the ROE and ROCE of Dr. Reddys Laboratories Ltd.?
Dr. Reddys Laboratories Ltd. has a Return on Equity (ROE) of 17.29% and a Return on Capital Employed (ROCE) of 17.21% as per the latest financial reports.
What is the market cap of Dr. Reddys Laboratories Ltd.?
The market capitalization of Dr. Reddys Laboratories Ltd. stands at ₹ 1,00,718.00 Cr.
What is the dividend yield of Dr. Reddys Laboratories Ltd.?
The dividend yield of Dr. Reddys Laboratories Ltd. is 0.66% based on the current market price.
What is the RSI of Dr. Reddys Laboratories Ltd.?
The Relative Strength Index (RSI) of Dr. Reddys Laboratories Ltd. is 30.61.
What is the FII and DII holding in Dr. Reddys Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 24.69% and Domestic Institutional Investors (DII) hold 25.24% of Dr. Reddys Laboratories Ltd. shares.
What sector does Dr. Reddys Laboratories Ltd. belong to?
Dr. Reddys Laboratories Ltd. operates in the Healthcare sector.
What is the beta of Dr. Reddys Laboratories Ltd. stock?
The beta of Dr. Reddys Laboratories Ltd. stock is 0.78, indicating its volatility relative to the broader market.
